| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group B Lacas, A Carmel, C Landais, SJ Wong, L Licitra, JS Tobias, B Burtness, ... Radiotherapy and Oncology 156, 281-293, 2021 | 276 | 2021 |
| Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement DJ Thomson, D Palma, M Guckenberger, P Balermpas, JJ Beitler, ... International Journal of Radiation Oncology* Biology* Physics 107 (4), 618-627, 2020 | 234 | 2020 |
| Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus H Mehanna, JC Hardman, JA Shenson, AK Abou-Foul, MC Topf, ... The Lancet Oncology 21 (7), e350-e359, 2020 | 124 | 2020 |
| Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck DJ Thomson, P Silva, K Denton, S Bonington, SK Mak, R Swindell, ... Head & neck 37 (2), 182-187, 2015 | 101 | 2015 |
| Evaluation of an automatic segmentation algorithm for definition of head and neck organs at risk D Thomson, C Boylan, T Liptrot, A Aitkenhead, L Lee, B Yap, A Sykes, ... Radiation Oncology 9, 1-12, 2014 | 93 | 2014 |
| NIMRAD–a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer D Thomson, H Yang, H Baines, E Miles, S Bolton, C West, N Slevin Clinical Oncology 26 (6), 344-347, 2014 | 75 | 2014 |
| Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis C Petit, B Lacas, JP Pignon, QT Le, V Grégoire, C Grau, A Hackshaw, ... The Lancet Oncology 22 (5), 727-736, 2021 | 70 | 2021 |
| Physical therapy for facial nerve paralysis (Bell's palsy): An updated and extended systematic review of the evidence for facial exercise therapy AJ Khan, A Szczepura, S Palmer, C Bark, C Neville, D Thomson, H Martin, ... Clinical rehabilitation 36 (11), 1424-1449, 2022 | 56 | 2022 |
| Radiation fractionation schedules published during the COVID-19 pandemic: A systematic review of the quality of evidence and recommendations for future development DJ Thomson, SS Yom, H Saeed, I El Naqa, L Ballas, SM Bentzen, ... International Journal of Radiation Oncology* Biology* Physics 108 (2), 379-389, 2020 | 55 | 2020 |
| Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma AM Tsakiroglou, M Fergie, K Oguejiofor, K Linton, D Thomson, PL Stern, ... British journal of cancer 122 (4), 539-544, 2020 | 47 | 2020 |
| The role of positron emission tomography in management of small cell lung cancer D Thomson, P Hulse, P Lorigan, C Faivre-Finn Lung cancer 73 (2), 121-126, 2011 | 46 | 2011 |
| Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029 C Marquina, S Talic, S Vargas-Torres, M Petrova, D Abushanab, A Owen, ... European Journal of Preventive Cardiology 29 (8), 1212-1219, 2022 | 45 | 2022 |
| TORPEdO-a phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer J Price, E Hall, C West, D Thomson Clinical oncology (Royal College of Radiologists (Great Britain)) 32 (2), 84-88, 2020 | 45 | 2020 |
| Proton beam therapy: perspectives on the National Health Service England clinical service and research programme NG Burnet, RI Mackay, E Smith, AL Chadwick, GA Whitfield, DJ Thomson, ... The British Journal of Radiology 93 (1107), 20190873, 2020 | 42 | 2020 |
| Indications for salivary gland radiotherapy. DJ Thomson, NJ Slevin, WM Mendenhall Advances in Oto-rhino-laryngology 78, 141-147, 2016 | 34 | 2016 |
| Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate-resistant prostate cancer D Thomson, N Charnley, O Parikh European Journal of Cancer 50 (5), 1040-1041, 2014 | 31 | 2014 |
| The routine clinical implementation of electronic patient-reported outcome measures (ePROMs) at The Christie NHS Foundation Trust C Crockett, F Gomes, C Faivre-Finn, S Howell, V Kasipandian, E Smith, ... Clinical Oncology 33 (12), 761-764, 2021 | 30 | 2021 |
| Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma DJ Thomson, KF Ho, L Ashcroft, K Denton, G Betts, KL Mais, K Garcez, ... Acta oncologica 54 (1), 88-98, 2015 | 30 | 2015 |
| Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma L Dixon, S Ramasamy, K Cardale, K Dyker, K Garcez, LW Lee, ... Radiotherapy and Oncology 128 (3), 452-458, 2018 | 28 | 2018 |
| Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismus C Hague, W Beasley, K Garcez, LW Lee, A McPartlin, A McWilliam, ... Acta Oncologica 57 (8), 1038-1042, 2018 | 28 | 2018 |
